Enzyme butilcholinesterase activity variation in hormonal contraception users

Authors

  • Llermén Vásquez Dirección Regional de Salud - Puno, EsSALUD, Puno, Perú
  • Jorge Osorio Complejo Hospitalario Clínica San Pablo, Lima, Perú

DOI:

https://doi.org/10.15381/anales.v61i4.4362

Keywords:

Contraceptives, oral, hormonal, norgestrel, medroxyprogesterone, butyrylcholinesterase, contraception

Abstract

OBJECTIVE: To evaluate enzyme butilcholinesterase activity in women using two hormonal contraceptives, norgestrel ethinylestradiol and medroxyprogesterone acetate, using alkaline phosphatase as indirect liver marker. MATERIAL AND METHODS: Women attending family planning program at El Agustino "7 de Octubre" health center, continuing users of hormonal contraception for over six months. Fasting blood was obtained and enzymatic activity was measured in serum. RESULTS: Users of both contraceptives had significant increase in butilcholinesterase activity compared with control group; medroxyprogesterone users had 30% more elevated values; 12% of norgestrel ethinylestradiol and 18% of medroxyprogesterone users had values beyond +/- 2SD. Alkaline phosphatase activity increased a significant 8% only in medroxyprogesterone users. CONCLUSIONS: Medroxyprogesterone acetate caused more and longer butilcholinesterase activity variation than oral norgestrel ethinylestradiol.
Vol 61, No 4 (2000)

Downloads

Published

2000-12-29

Issue

Vol. 61 No. 4 (2000)

Section

Trabajos originales

License

Copyright (c) 2000 Llermén Vásquez, Jorge Osorio

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Those authors who have publications with this magazine accept the following terms:

  1. Authors will retain their copyrights and guarantee the journal the right of first publication of their work, which will be simultaneously subject to Creative Commons Attribution License that allows third parties to share the work as long as its author and its first publication this magazine are indicated.
  2. Authors may adopt other non-exclusive licensing agreements for the distribution of the version of the published work (eg, deposit it in an institutional electronic file or publish it in a monographic volume) provided that the initial publication in this magazine is indicated.
  3. Authors are allowed and recommended to disseminate their work over the Internet (eg: in institutional telematic archives or on their website) before and during the submission process, which It can produce interesting exchanges and increase quotes from the published work. (See El efecto del acceso abierto ).

How to Cite

1.
Vásquez L, Osorio J. Enzyme butilcholinesterase activity variation in hormonal contraception users. An Fac med [Internet]. 2000 Dec. 29 [cited 2024 Jul. 17];61(4):271-7. Available from: https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/4362